Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particles but not with amino acids
Circulating apolipoprotein E concentration and cardiovascular disease risk: meta-analysis of results from three studies
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study
Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in Coronary Heart Disease: modified Mendelian randomization analysis using PLA2G5 expression levels